Showing results (11-20 of 1,273) with videos related to

Sort By:
Pageof 128
Clinical Colorectal Cancer|December 26, 2015
Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant OxaliplatinStacey A Cohen, Chen Wu, Ming Yu, et al.
Clinical Colorectal Cancer|February 3, 2016
Outcomes of Young Patients With Rectal Cancer From a Tertiary Cancer Care Centre in IndiaK P Haresh, Rony Benson, Supriya Mallick, et al.
Clinical Colorectal Cancer|January 19, 2016
Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study)Tomohiro Nishina, Toshikazu Moriwaki, Mitsuo Shimada, et al.
Clinical Colorectal Cancer|January 19, 2016
Adenocarcinoma of the Rectum-A Composite of Three Different Subtypes With Varying Outcomes?Karthik Chandra Vallam, Ashwin Desouza, Munita Bal, et al.
Clinical Colorectal Cancer|January 10, 2016
Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?Elizabeth C Smyth, Noelia Tarazona, Clare Peckitt, et al.
Clinical Colorectal Cancer|June 2, 2016
Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic BiomarkerOriol Caritg, Alfons Navarro, Isabel Moreno, et al.
Clinical Colorectal Cancer|April 17, 2016
Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance ProgramRosario Fornaro, Michela Caratto, Elisa Caratto, et al.
Clinical Colorectal Cancer|March 17, 2016
Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review StudyKatia Bencardino, Gianluca Mauri, Alessio Amatu, et al.
Clinical Colorectal Cancer|November 8, 2017
Cost-effectiveness of Trifluridine/tipiracil for Previously Treated Metastatic Colorectal Cancer in England and WalesAsh Bullement, Stuart Underhill, Ronan Fougeray, et al.
Clinical Colorectal Cancer|August 13, 2016
Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the CommunityBruno Mendonça Protásio, Adriana Matutino, Liana Valente Lage, et al.
Pageof 128